Basic Information
Basic information for AC006115.2-216-31aa
Peptide Name AC006115.2-216-31aa
Genome Position chr19:56798572-56798664[+]
Species Human
Peptide Sequence MPKAVATKAKIDKWNLIKLKSFCTAKKLSSE
Peptide Length 31
Unique No (AC006115.2-202-31aa,AC006115.2-218-31aa,AC006115.2-211-31aa,AC006115.2-215-31aa,ZIM2-AS1-201-31aa,AC006115.2-213-31aa,AC006115.2-212-31aa,AC006115.2-217-31aa,AC006115.2-220-31aa,AC006115.2-210-31aa)
Grand Average of Hydropathicity -0.2903
Relative Molecular Mass 4019.73
Experimental Evidences no
lncRNA ID/Name ENSG00000286125;AC006115.2
Transcript ID/Name ENST00000651337;AC006115.2-216
Transcript Length 2200
Coding Ability 0.4473
DNA Sequence Corresponding to Peptide ATGCCAAAAGCAGTAGCAACAAAAGCAAAAATTGACAAATGGAATCTAATTAAACTAAAGAGCTTCTGTACAGCAAAGAAATTATCATCAGAG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :